Although the drug can slow the progression of cognitive decline, it may have little impact on damage already done by AD prior to treatment.

Sports fans may actually be emotionally dependent on their team’s performance on a neural level, according to functional imaging data. 

Researchers are hopeful their new approach to developing MRI contrast will "pave the way for safer, smarter imaging in clinical diagnostics."

Researchers tracked data from nearly 8,000 patients evaluated with Heartflow's FDA-cleared Plaque Analysis software. Overall, the technology's Plaque Staging feature was found to provide significant value during the diagnosis and management of these patients.

The new drug from Merck was linked to several benefits for patients who are already on statins. If an oral PCSK9 inhibitor gains FDA approval, it could be a game-changer for the field of preventive medicine. 

Consistently incorporating unsalted peanuts into a person’s diet enhances cerebral blood flow to multiple brain regions. 

Noninvasive coronary CT angiography is growing more and more important as time goes on, helping cardiologists make critical treatment decisions. Carlos Collet, MD, PhD, discussed the technique's potential to be a real game-changer for patient care in a new interview. 

Taking melatonin for a year could increase a person's risk of developing heart failure by 90%. While more research is still needed to confirm these findings, the data suggest patients should think twice about relying on melatonin to sleep.